We are live on ! Find out more
OAM

Oxford Asset Management Portfolio holdings

AUM $232M
1-Year Est. Return 31%
This Fund
S&P 500
This Quarter Est. Return
-10.3%
1 Year Est. Return
+31%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.85B
AUM Growth
-$949M
Cap. Flow
-$393M
Cap. Flow %
-10.22%
Top 10 Hldgs %
10.07%
Holding
2,323
New
652
Increased
471
Reduced
539
Closed
577

Sector Composition

Rank Sector Weight
1 Technology 15.44%
2 Consumer Discretionary 14.53%
3 Healthcare 13.43%
4 Industrials 13.16%
5 Financials 12.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CXO
1151
DELISTED
CONCHO RESOURCES INC.
CXO
$557K 0.01%
+5,418
New +$719K
MNR
1152
DELISTED
Monmouth Real Estate Investment Corp
MNR
$553K 0.01%
+44,594
New +$649K
MCY icon
1153
Mercury Insurance
MCY
$6.07B
$552K 0.01%
10,666
-10,522
-50% -$572K
QTTB icon
1154
Q32 Bio
QTTB
$464M
$552K 0.01%
+1,371
New +$518K
HBIO icon
1155
Harvard Bioscience
HBIO
$29.2M
$550K 0.01%
17,309
-3,694
-18% -$146K
JBGS
1156
JBG SMITH
JBGS
$708M
$550K 0.01%
15,789
-72,039
-82% -$2.71M
CNACR
1157
DELISTED
Constellation Alpha Capital Corp. Right
CNACR
$550K 0.01%
2,873,973
+675,000
+31% +$160K
IBB icon
1158
iShares Biotechnology ETF
IBB
$9.71B
$548K 0.01%
5,684
-535
-9% -$56.8K
OMF icon
1159
OneMain Financial
OMF
$7.47B
$548K 0.01%
+22,543
New +$641K
MSC
1160
Studio City International Holdings
MSC
$349M
$547K 0.01%
+32,726
New +$591K
FNJN
1161
DELISTED
Finjan Holdings, Inc.
FNJN
$545K 0.01%
217,263
+109,854
+102% +$367K
PRLB icon
1162
Protolabs
PRLB
$2.13B
$544K 0.01%
+4,826
New +$595K
CMRX
1163
DELISTED
Chimerix, Inc.
CMRX
$544K 0.01%
211,525
+17,893
+9% +$59.9K
KRA
1164
DELISTED
Kraton Corporation
KRA
$544K 0.01%
24,916
-41,793
-63% -$1.23M
WASH icon
1165
Washington Trust Bancorp
WASH
$741M
$538K 0.01%
11,320
+2,497
+28% +$128K
HMTV
1166
DELISTED
Hemisphere Media Group, Inc.
HMTV
$538K 0.01%
44,283
-3,139
-7% -$41.9K
MRUS
1167
DELISTED
Merus
MRUS
$536K 0.01%
38,319
-9,530
-20% -$138K
VTIQW
1168
DELISTED
VectoIQ Acquisition Corp. Warrant
VTIQW
$535K 0.01%
1,070,000
ATRA icon
1169
Atara Biotherapeutics
ATRA
$76.1M
$534K 0.01%
+615
New +$571K
COHR
1170
DELISTED
Coherent Inc
COHR
$534K 0.01%
+5,052
New +$649K
FATE icon
1171
Fate Therapeutics
FATE
$326M
$530K 0.01%
+41,289
New +$576K
FOMX
1172
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$530K 0.01%
147,755
-42,898
-23% -$187K
UVV icon
1173
Universal Corp
UVV
$1.27B
$529K 0.01%
9,768
+2,340
+32% +$151K
UXIN
1174
Uxin Ltd
UXIN
$282M
$529K 0.01%
+1,089
New +$630K
ALL icon
1175
Allstate
ALL
$67.5B
$527K 0.01%
6,373
-96,850
-94% -$8.7M

Similar funds

Oxford Asset Management's Q4 2018 Portfolio in Review

As of Q4 2018, Oxford Asset Management held 2,323 positions worth $3.85B, down 20% from $4.8B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Oxford Asset Management withdrew a net $393M in Q4 2018, closing 577 positions and reducing 539 holdings. Its most notable exit was Envision Healthcare Holdings Inc, an estimated $105M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Oxford Asset Management opened a new position in Athenahealth, Inc. worth $69.9M.

  • Oxford Asset Management's largest Q4 2018 buy was Athenahealth, Inc.: 530,000 shares worth $69.9M.
  • Oxford Asset Management added most to Integrated Device Technology I in Q4 2018, an estimated $34.6M increase.
  • Oxford Asset Management's biggest Q4 2018 reduction was GE Aerospace, cutting an estimated $18.1M.
  • Oxford Asset Management fully exited Envision Healthcare Holdings Inc in Q4 2018, selling an estimated $105M.
  • Oxford Asset Management's ten largest holdings make up 10% of its $3.85B portfolio in Q4 2018.
  • Oxford Asset Management opened 652 new positions and closed 577 in Q4 2018.
  • Oxford Asset Management's portfolio value fell 20% quarter-over-quarter to $3.85B.

Based on Oxford Asset Management's 13F filing for Q4 2018, filed 14 Feb 2019.